Parsing the Evidence from the EMBARK ... - Advanced Prostate...
Parsing the Evidence from the EMBARK Trial on a Promising New Drug Regimen in High-Risk Non-Metastatic Hormone-Sensitive Prostate Cancer
Written by
Maxone73
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
Thanks...at least for me, a great review of latest studies...for men with non-metastatic (per PSMA PET scan) BCR after surgery or RT. Right? Oncologists increasingly reluctant o immediately subject patients to traditional ADT.
Not what you're looking for?
You may also like...
FDA Approves Darolutamide Plus Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer
axel-in-metastatic-hormone-sensitive-prostate-cancer
More info:
https://www.urotoday.com/confere
Enzalutamide Extends Radiographic PFS in Metastatic Hormone-Sensitive Prostate Cancer
https://www.ascopost.com/issues/april-10-2019-supplement-conference-highlights-gugi-2019/interim-ana
Combination therapy in metastatic hormone-sensitive prostate cancer: is three a crowd?
This is quite new, have you seen this already
This is for Hormone sensitive men....
New blood test for prostate cancer is highly-accurate and avoids invasive biopsies
Interesting article from Science Daily.
I did not experience any pain, bleeding or infection when I...
Recent discussion with Dr. Denmeade. BAT
Anyone Know of Dr. Gary Onik. AKA Dr. Hope
11 months since diagnosis
Laetrile - Conspiracy Theory or Truth?
